IGFBP7 and acute kidney injury: In the ‘Biomarker-guided intervention to prevent AKI after major surgery (BigPAK)’ trial, a similar care bundle including early optimization of fluids and maintenance of perfusion pressure, was applied to patients after non-cardiac major surgery who were testing positive for the urinary [TIMP-2] × [IGFBP7] biomarker [27].